Noevir Holdings Co., Ltd.

As of March 31, 2026, Noevir Holdings Co., Ltd. carries a market capitalization of 154.39B, placing it among publicly traded companies globally. Its enterprise value stands at 132.29B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Noevir Holdings Co., Ltd.'s next confirmed earnings release is scheduled for November 10, 2026.

As of March 31, 2026, Noevir Holdings Co., Ltd. has 34.16M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Noevir Holdings Co., Ltd. maintains a current ratio of 4.50, meaning it holds 4.5x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 22, 2026, Noevir Holdings Co., Ltd.'s stock has gained approximately 5.39% over the past 52 weeks. The 50-day moving average sits at 4,736.90, while the 200-day moving average is 4,576.00.

As of March 31, 2026, Noevir Holdings Co., Ltd. holds 23.42B in cash and equivalents against 699.00M in total debt, resulting in a net debt position of -23.42B. Total book value stands at 48.86B, with working capital of 35.30B providing operational flexibility.